EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Clinical validation of a patient‐friendly saliva microsampling approach to monitor perampanel levels in people with epilepsy

Valentina Franco iD, Francesca Dattrino iD, Michela Palmisani iD, Federica Tacchella iD, Elena Tartara iD, Valentina De Giorgis iD, Carlo Alberto Quaranta iD, Ludovica Pasca iD, Paola Rota iD, Emilio Russo iD, Andrea Romigi iD, Cecilie Johannessen Landmark iD und 3 weitere

Epilepsia · 2026-07 · 67 (7)

DOI: 10.1002/epi.70302 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Epilepsia, online erschienen am 22.05.2026. Verfasst von Valentina Franco und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. Hauptthemen laut MEDLINE: Saliva, Anticonvulsants, Drug Monitoring, Pyridones. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perampanel (PER) is a third‐generation antiseizure medication (ASM) with a well‐established concentration–effect relationship. Saliva represents a non‐invasive alternative to plasma for therapeutic drug monitoring (TDM) of PER, as it reflects the free plasma fraction. Volumetric absorptive microsampling (VAMS) enables standardized, patient‐friendly saliva collection. This study aimed to clinically validate saliva‐VAMS by directly comparing it with conventional liquid saliva sampling for PER quantification. In a prospective study, saliva was collected from 11 people with epilepsy receiving PER therapy (dose range = 2–10 mg/day) using both VAMS and conventional saliva sampling. PER concentrations were measured by liquid chromatography coupled with tandem mass spectrometry and compared using repeated measures Bland–Altman analysis and Lin's concordance correlation coefficient to evaluate agreement between methods. PER concentrations measured in saliva‐VAMS showed excellent agreement with those obtained from conventional saliva sampling, with mean bias of −0.126 ng/mL (95% confidence interval = −0.582 to 0.330). No relevant constant or proportional bias was observed, and limits of agreement were within predefined acceptance criteria. Concordance between methods was high, supporting analytical equivalence. The demonstrated interchangeability between saliva‐VAMS and conventional saliva sampling supports adoption of saliva‐VAMS in clinical TDM workflows, enabling standardized fixed‐volume collection, simplified storage/transport, and potential home‐based sampling for remote dose optimization of PER and potentially other ASMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SalivaAnticonvulsantsDrug MonitoringPyridonesEpilepsySpecimen HandlingHumansNitrilesFemaleAdultMaleProspective StudiesTandem Mass SpectrometryMiddle AgedYoung AdultChromatography, Liquid

Stichwörter der Autor:innen

microsamplingperampanelsalivatherapeutic drug monitoring

Substanzen

NitrilesAnticonvulsantsperampanelPyridones

Autor:innen und Institutionen

  • Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
  • IRCCS Mondino Foundation, Pavia, Italy.
  • IRCCS Mondino Foundation, full member of European Reference Network EpiCARE, Pavia, Italy.
  • Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, full member of European Reference Network EpiCARE, Pavia, Italy.
  • Department of Biomedical, Surgical, and Dental Sciences, University of Milan, Milan, Italy.

ORCID-Profile: Valentina Franco, Francesca Dattrino, Michela Palmisani, Federica Tacchella, Elena Tartara, Valentina De Giorgis, Carlo Alberto Quaranta, Ludovica Pasca, Paola Rota, Emilio Russo, Andrea Romigi, Cecilie Johannessen Landmark, Cristina Tassorelli

Zitieren

APA

Franco, V., Dattrino, F., Palmisani, M., Tacchella, F., Tartara, E., De Giorgis, V., Quaranta, C. A., Pasca, L., Rota, P., Russo, E., Romigi, A., Johannessen Landmark, C., Fedele, G., Tassorelli, C., & Nicotera, P. (2026). Clinical validation of a patient‐friendly saliva microsampling approach to monitor perampanel levels in people with epilepsy. Epilepsia, 67(7). https://doi.org/10.1002/epi.70302

Vancouver

Franco V, Dattrino F, Palmisani M, Tacchella F, Tartara E, De Giorgis V, et al. Clinical validation of a patient‐friendly saliva microsampling approach to monitor perampanel levels in people with epilepsy. Epilepsia. 2026;67(7). doi:10.1002/epi.70302

BibTeX
@article{Franco2026,
  author = {Franco, Valentina and Dattrino, Francesca and Palmisani, Michela and Tacchella, Federica and Tartara, Elena and De Giorgis, Valentina and Quaranta, Carlo Alberto and Pasca, Ludovica and Rota, Paola and Russo, Emilio and Romigi, Andrea and Johannessen Landmark, Cecilie and Fedele, Guido and Tassorelli, Cristina and Nicotera, Pierluigi},
  title = {Clinical validation of a patient‐friendly saliva microsampling approach to monitor perampanel levels in people with epilepsy},
  journal = {Epilepsia},
  year = {2026},
  volume = {67},
  number = {7},
  doi = {10.1002/epi.70302}
}
Kostenlos starten →